FDA Brief

Company record

MEDVi, LLC dba MEDVi

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about MEDVi, LLC dba MEDVi.

Warning letters

  1. MEDVi, LLC dba MEDVi

    FDA says telehealth seller MEDVi misbranded compounded semaglutide and tirzepatide by implying MEDVi makes them and that they are FDA-approved.

    Medium